<PAGE> 1
[ECLIPSYS CORPORATION LETTERHEAD]
Contact:
Eclipsys: Randy L. Thomas, Corporate Strategy and Marketing (media)
(561) 266-2348 - [email protected]
Greg Wilson, CFO (investors)
(561) 266-2324 - [email protected]
ECLIPSYS SETS DATE OF 2000 ANNUAL MEETING
DELRAY BEACH, FL -- MAY 30, 2000 -- Eclipsys Corporation(R) (NASDAQ: ECLP) today
announced that it has scheduled its 2000 Annual Meeting of Stockholders to be
held at the Delray Beach Marriott, 10 North Ocean Boulevard, Delray Beach,
Florida 33444 on Wednesday, July 12, 2000, at 10:00 a.m. to consider and vote
upon the following matters:
1. To elect two Class II directors for the ensuing three years.
2. To approve the Company's 2000 Stock Incentive Plan.
3. To approve related amendments to the Company's 1998 Stock Incentive Plan,
1999 Stock Incentive Plan, and Amended and Restated 1998 Employee Stock
Purchase Plan.
4. To ratify the selection by the Board of Directors of Pricewaterhouse
Coopers LLP as the Company's independent auditors for the current fiscal
year.
5. To transact such other business as may properly come before the meeting
or any adjournment or postponement thereof.
Stockholders of record at the close of business on June 15, 2000 will be
entitled to notice of and to vote at the meeting or any adjournment or
postponement thereof. The stock transfer books of the Company will remain open
following the record date. The Company's Board of Directors has nominated Jay B.
Pieper for reelection as a Class II director and Steven A. Denning, currently a
Class III director, for election as a Class II director. Two of the Company's
current Class II directors, J. Robert Kell and Patrick T. Hackett, are not
standing for reelection. The Company is not aware of any disagreement of these
directors with Company on any matters relating to the Company's operations,
policies or practices. Stockholders wishing to nominate any person for election
as a Class II director or to bring any other matter before the Annual Meeting,
including stockholder proposals, must mail or deliver notice of the nomination
or other matter prior to the close of business on June 9, 2000 to the Secretary
of the Company, in the form and in accordance with the procedures prescribed by
the Company's Amended and Restated By-Laws.
<PAGE> 2
ABOUT ECLIPSYS
Eclipsys Corporation (www.eclipsys.com) delivers end-to-end information
solutions that enable healthcare enterprises to achieve balanced and improved
clinical, financial and customer-satisfaction outcomes. Solutions include its
comprehensive, knowledge-based Sunrise software line; leading-edge enterprise
application integration (EAI) solutions; application services provider (ASP)
information-management solutions; business process reengineering; network design
and implementation; and full IT outsourcing. In conjunction with its
HEALTHvision affiliate (see www.healthvision.com), Eclipsys provides customized,
locally branded Web-based solutions to healthcare delivery systems. Eclipsys has
more than 1,400 customer organizations throughout the U.S. and in 17 other
countries. For more information, contact Investor Relations at
[email protected] or by calling (561) 266-2324.
##########
No solicitation of proxies relating to the 2000 Annual Meeting is being made at
this time. Stockholders are urged to read the proxy materials concerning the
2000 Annual Meeting when they become available because they will contain
important information concerning the meeting. Statements in this news release
concerning future results, performance or expectations are forward-looking
statements. Because such statements involve risks and uncertainties, actual
results may differ materially from those expressed or implied by such
forward-looking statements. These risks include risks described in the filings
of Eclipsys with the Securities and Exchange Commission. Eclipsys undertakes no
obligation to update the information contained in this press release. Eclipsys,
Eclipsys Corporation and The Outcomes Company are registered trademarks and
Sunrise is a trademark of Eclipsys Solutions Corp. Other product and company
names in this news release are trademarks or registered trademarks of their
respective companies.
